Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 8
2022 10
2023 5
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Total neoadjuvant therapy in early-onset versus average-onset locally advanced rectal cancer: patient characteristics and tolerance of therapy.
Conces ML, Tursun N, Ozgur I, Yilmaz S, Elamin D, Patil S, Bouferraa Y, Gorgun E, Liska D, Weinstein E, Kamath SD, Steele SR, Khorana AA, Laderian B, Jayakrishnan TT, Nair KG, Amarnath SR, Balagamwala EH, Estfan BN, Kessler H, McNamara MJ, Shapiro MA, Valente MA, Krishnamurthi SS. Conces ML, et al. Among authors: bouferraa y. ESMO Gastrointest Oncol. 2025 Apr 28;8:100170. doi: 10.1016/j.esmogo.2025.100170. eCollection 2025 Jun. ESMO Gastrointest Oncol. 2025. PMID: 41646283 Free PMC article.
Adagrasib in the treatment of colorectal cancer.
Haddad SF, Bouferraa Y, Nair KG. Haddad SF, et al. Among authors: bouferraa y. Future Oncol. 2025 Aug;21(18):2275-2285. doi: 10.1080/14796694.2025.2524311. Epub 2025 Jul 6. Future Oncol. 2025. PMID: 40619745 Free PMC article. Review.
Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced microsatellite stable rectal adenocarcinoma: The Averectal study.
Shamseddine A, Turfa R, Chehade L, Zeidan YH, El Husseini Z, Kreidieh M, Bouferraa Y, Elias C, Kattan J, Khalifeh I, Mukherji D, Temraz S, Shaib Y, Soweid A, Alqasem K, Amarin R, Awabdeh TA, Deeba S, Doughan S, Mohamad I, El Khaldi M, Daoud F, Masri MA, Dabous A, Hushki A, Jaber O, Jamali F, Charafeddine M, Darazi MA, Geara F. Shamseddine A, et al. Among authors: bouferraa y. Eur J Cancer. 2025 Jun 3;222:115428. doi: 10.1016/j.ejca.2025.115428. Epub 2025 Apr 22. Eur J Cancer. 2025. PMID: 40286473 Clinical Trial.
Addendum: Systemic AL amyloidosis: current approach and future direction.
Bou Zerdan M, Nasr L, Khalid F, Allam S, Bouferraa Y, Batool S, Tayyeb M, Adroja S, Mammadii M, Anwer F, Raza S, Chaulagain CP. Bou Zerdan M, et al. Among authors: bouferraa y. Oncotarget. 2023 Jul 20;14:721. doi: 10.18632/oncotarget.28478. Oncotarget. 2023. PMID: 37477528 Free PMC article. No abstract available.
Systemic AL amyloidosis: current approach and future direction.
Bou Zerdan M, Nasr L, Khalid F, Allam S, Bouferraa Y, Batool S, Tayyeb M, Adroja S, Mammadii M, Anwer F, Raza S, Chaulagain CP. Bou Zerdan M, et al. Among authors: bouferraa y. Oncotarget. 2023 Apr 26;14:384-394. doi: 10.18632/oncotarget.28415. Oncotarget. 2023. PMID: 37185672 Free PMC article. Review.
The Gut Microbiome and Alzheimer's Disease: A Growing Relationship.
Bou Zerdan M, Hebbo E, Hijazi A, El Gemayel M, Nasr J, Nasr D, Yaghi M, Bouferraa Y, Nagarajan A. Bou Zerdan M, et al. Among authors: bouferraa y. Curr Alzheimer Res. 2022;19(12):808-818. doi: 10.2174/1567205020666221227090125. Curr Alzheimer Res. 2022. PMID: 36578263
25 results